Ads
related to: sanofi stock
Search results
French pharma Sanofi announces stock purchase plan for employees
dpa international via Yahoo Finance· 20 hours agoFrench pharmaceutical firm Sanofi has announced its stock purchase plan for employees for this year....
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 20 hours agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More
Zacks via Yahoo Finance· 20 hours agoJ&J (JNJ) and Merck (MRK) announce the acquisitions of private biotechs. The FDA grants Priority...
Sanofi's (SNY) Sarclisa sBLA Gets FDA's Priority Review Tag
Zacks via Yahoo Finance· 5 days agoThe FDA grants priority review to Sanofi's (SNY) sBLA for the Sarclisa combination regimen for...
PNC Financial Services Group Inc. Sells 93,285 Shares of Sanofi (NASDAQ:SNY)
ETF DAILY NEWS· 7 days agoPNC Financial Services Group Inc. lowered its position in Sanofi (NASDAQ:SNY – Free Report) by 48.1% during the fourth quarter, Holdings Channel reports. The institutional ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 23 hours agoNow in its 10th year, the program demonstrates the ongoing commitment of Sanofi and its Board of Directors to secure that employees benefit from the company growth and success ...
3 Artificial Intelligence (AI) Stocks That Could Go Parabolic
Motley Fool via Yahoo Finance· 1 day agoThere has simply not been a data-analysis option powerful enough to pay for ... until now....
CAC 40 Struggles For Direction As Inflation Accelerates
RTT News· 1 day agoFrench stocks struggled for direction on Friday after data showed consumer prices in the country rose at a faster rate this month due to higher energy prices. Consumer prices rose an average ...
FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
Benzinga via Yahoo Finance· 18 hours agoOn Friday, the FDA extended the target action date of priority review of supplemental application...
Sanofi’s CEO thinks OpenAI offers 'insane' potential for the pharmaceutical industry
Fortune· 3 days agoIf generative AI is going to be more than hype and hallucinations, the trillion-dollar pharma industry is where the magic may happen. Last week, Hudson proudly announced his company’s new partnership ...